Investigator Initiated Grants (John D. Carter, MD)

  • Regional Grants in Aid (RGIA)

    "The Effect of a Low Carbohydrate, High Protein/Fat Diet on Bone Turnover."
    Granting Agency: Procter & Gamble (Investigator Initiated Grant)
    Awarded August 2004
    Completed May 2006; published 2006
    Amount Awarded: $17,675.00
    Principal Investigator
  • Unrestricted Fellowship Educational Grant

    "Training Fellows to Perform Clinical Research."
    Granting Agency: Amgen
    Awarded August 2004
    Completed December 2004
    Amount Awarded: $2500.00
    Principal Investigator
  • Investigator Initiated Grants Initiative

    "Male Osteoporosis: Recognition & Treatment."
    Granting Agency: Merck (Investigator Initiated Grant)
    Awarded October 2004
    Project completed; manuscript in press
    Amount Awarded: $24,835.00
    Principal Investigator
  • NIH Exploratory/Developmental Research Grant Award (R21)

    "Combination Antimicrobial Therapy as a Treatment for Chlamydia-Induced Reactive Arthritis."
    National Institutes of Health (National Institute of Musculoskeletal and Skin Diseases [NIAMS])
    International Multi-Center Trial (4 Study Sites)
    Assignment Number: 1 R21 AR053646-01
    Start Date May 22, 2006
    Stop Date April, 2009
    Amount Awarded: $415,031.00
    Principal Investigator
  • "A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis."

    Sponsor: Genentech
    Amount: $501,125.00 (with the potential of $698,945.00 based on study extension)
    Status: Regulatory & Trial Initiation Phase
    Project: November, 2006 – January, 2010
    Target Enrollment: 50 patients
    Principal Investigator
  • "MRI and Ultrasound Findings in Patients with Gout and Normal Plain Radiographs."

    Sponsor: TAP Pharmaceuticals
    Principal Investigator
  • "Shifting the Paradigm of Gout: An Assessment of Chronic Synovial-Based Inflammation and its Role with Serum Urate Levels."

    Sponsor: Takeda Pharmaceuticals
    Principal Investigator